Business
Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors
Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors.
About this update from Bioasis Technologies Inc.
[{"type":"text","content":"\n \n BIOASIS \n TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, \n research-stage biopharmaceutical company developing its proprietary xB3 \n TM platform technology for the delivery of therapeutics across the \n blood-brain barrier (the “BBB”) and the treatment of central \n nervous system (“CNS”) disorders in areas of high unmet medical \n need, including brain cancers and neurodegenerative diseases, today \n announced the appointment of Mario Saltarelli, M.D., Ph.D., as \n non-executive director of the Bioasis board of directors. Dr. Saltarelli \n served on Bioasis’ scientific advisory board (SAB) since June 2018.\n \n \n “I am delighted to welcome Mario as the non-executive director of the \n Bioasis board. With a proven track record of building successful \n pipelines and programs, he brings to our board his broad leadership \n experience across multiple aspects of drug discovery and clinical \n development, with a focus in diseases of the central nervous system,” \n said Deborah Rathjen, Ph.D., Executive Chair and President & Chief \n Executive Officer of Bioasis. “We look forward to continuing to benefit \n from Mario’s expertise as we advance our xB3 programs toward \n the clinic.”\n \n \n Dr. Saltarelli has over 20 years of leadership experience in the \n biopharmaceutical industry. Currently, he is Chief Medical Officer (CMO) \n at Entrada Therapeutics, and held CMO positions at Syntimmune and \n Annexon Biosciences. He previously held executive leadership positions \n at Vertex, Mallinckrodt, Shire, AbbVie, and Pfizer. Prior to entering \n the pharmaceutical industry, Dr. Saltarelli was an Assistant Professor \n of Neurology at Emory University School of Medicine in Atlanta. Dr. \n Saltarelli holds an M.D. and a Ph.D. in neuroscience from Johns Hopkins \n University School of Medicine in Baltimore and also completed his \n neurology residency training at Johns Hopkins Hospital. Dr. Saltarelli \n earned his B.S. in psychology from the University of Illinois at \n Urbana-Champaign.\n \n \n “After having had the opportunity to contribute to Bioasis this past \n year as a member of the Scientific Advisory Board, I am thrilled to \n continue to advance my role within a company that I believe has...